Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy

Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy

Background. Huachansu, the sterilized water extract of Bufo bufo gargarizans toad skin, is used in China to alleviate the side-effects and enhance the therapeutic effect of chemotherapy in advanced non-small-cell lung cancer (NSCLC). We conducted a meta-analysis to assess Huachansu’s efficacy. Metho...

Full description

Bibliographic Details
Main Authors:	Bingduo Zhou, Fengying Wu, Lin Yuan, Zhulei Miao, Shengliang Zhu
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2015/408145

Similar Items

Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
by: J L Xu, et al.
Published: (2015-01-01)

Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated  with More Than Two Lines of Chemotherapy
by: Yi YIN, et al.
Published: (2018-06-01)

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
by: Dai P, et al.
Published: (2018-02-01)

Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation
by: Jihan Huang, et al.
Published: (2020-04-01)

Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway
by: Tengyang Ni, et al.
Published: (2019-10-01)

Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
by: Biaoxue Rong, et al.
Published: (2012-08-01)

Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer
by: Sheng YANG, et al.
Published: (2016-05-01)

Comparison of the Efficacy and Safety of Icotinib with Standard Second-line  Chemotherapy in Previously Treated Advanced Non-small Cell Lung Cancer
by: Shuyang YAO, et al.
Published: (2015-06-01)

Efficacy and safety profile of combining vandetanib with chemotherapy in patients with advanced non-small cell lung cancer: a meta-analysis.
by: Wei Tian, et al.
Published: (2013-01-01)

New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
by: Chien-shan Cheng, et al.
Published: (2019-04-01)

Metronomic Chemotherapy - A New Path to Treat Advanced Non-small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2015-04-01)

Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis.
by: Ting Wang, et al.
Published: (2013-01-01)

Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
by: Tao ZHANG, et al.
Published: (2013-02-01)

Impact of Anemia on Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
by: Chong'an XU, et al.
Published: (2010-10-01)

Evaluation of Efficacy of Gefitinib on Advanced non-small-cell Lung Cancer (NSCLC) Resisted to Chemotherapy
by: Jiangjiang TU, et al.
Published: (2008-04-01)

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis
by: Yanning Wang, et al.
Published: (2020-09-01)

The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.
by: Jin Sheng, et al.
Published: (2015-01-01)

Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis
by: Bei‐Bei Zhang, et al.
Published: (2020-05-01)

Advances of maintenance chemotherapy on advanced non-small cell lung cancer
by: Xinghao AI, et al.
Published: (2008-02-01)

Comparative Efficacy and Safety of Immunotherapy Alone and in Combination With Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Xue Wang, et al.
Published: (2021-03-01)

The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
by: Huang J, et al.
Published: (2016-09-01)

Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy
by: Melissa Bersanelli, et al.
Published: (2014-09-01)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
by: Mani Akhtari, et al.
Published: (2016-06-01)

Cytotoxic chemotherapy in advanced non-small cell lung cancer
by: G.V. Scagliotti, et al.
Published: (2005-12-01)

Advance of second-line chemotherapy in advanced non-small cell lung cancer
by: Li ZHANG
Published: (2008-02-01)

Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
by: André Bacellar Costa Lima, et al.
Published: (2011-01-01)

Kanglaite Injection Combined with Chemotherapy versus Chemotherapy Alone for the Improvement of Clinical Efficacy and Immune Function in Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Jianxia Wen, et al.
Published: (2020-01-01)

A meta-analysis of Pemetrexed plus Platinum Chemotherapy versus Gemcitabine plus Platinum Chemotherapy for Advanced Non-small Cell Lung Cancer
by: Jin JIANG, et al.
Published: (2011-01-01)

The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
by: Xingsheng Hu, et al.
Published: (2015-01-01)

Correlation of DLL3 Expression with Platinum-based Chemotherapy Efficacy and Prognosis of Advanced Small Cell Lung Cancer
by: HAN Shuhua, et al.
Published: (2020-11-01)

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer
by: Chen Lin, et al.
Published: (2020-04-01)

Evaluation of Efficacy and Safety of Bevacizumab Combined with Chemotherapy  for Chinese Patients with Advanced Non-small Cell Lung Cancer
by: Xiao ZHAO, et al.
Published: (2012-01-01)

Efficacy and safety comparisons of immunotherapy, anti-angiogenesis, and chemotherapy in advance-stage non-small cell lung cancer: a systemic reviews and network meta-analysis
by: Jia-Lian Yang, et al.
Published: (2017)

Febrile neutropenia in chemotherapy treated small-cell lung cancer patients
by: Kukec Renata Rezonja, et al.
Published: (2015-06-01)

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
by: Deyan Davidov
Published: (2014-12-01)

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy
by: Chang B, et al.
Published: (2017-09-01)

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
by: Bearz Alessandra, et al.
Published: (2008-07-01)

PD-L1 Expression and Survival among Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy
by: Steffen Filskov Sorensen, et al.
Published: (2016-02-01)

Duration of chemotherapy for small cell lung cancer: a meta-analysis.
by: Hang Zhou, et al.
Published: (2013-01-01)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
by: Tang N, et al.
Published: (2016-07-01)